Cargando…
Effects of Two Chinese Herbal Formulae for the Treatment of Moderate to Severe Stable Chronic Obstructive Pulmonary Disease: A Multicenter, Double-Blind, Randomized Controlled Trial
OBJECTIVE: The study aims to evaluate the efficacy and safety of two Chinese herbal formulae for the treatment of stable COPD. METHODS: A multicenter, double-blind, double-dummy, and randomized controlled trial (RCT) was conducted. All groups were treated with additional conventional medicines. Ther...
Autores principales: | Wang, Genfa, Liu, Baojun, Cao, Yuxue, Du, Yijie, Zhang, Hongying, Luo, Qingli, Li, Bei, Wu, Jinfeng, Lv, Yubao, Sun, Jing, Jin, Hualiang, Wei, Kai, Zhao, Zhengxiao, Kong, Lingwen, Zhou, Xianmei, Miao, Qing, Wang, Gang, Zhou, Qingwei, Dong, Jingcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132093/ https://www.ncbi.nlm.nih.gov/pubmed/25118962 http://dx.doi.org/10.1371/journal.pone.0103168 |
Ejemplares similares
-
Correction: Effects of Two Chinese Herbal Formulae for the Treatment of Moderate to Severe Stable Chronic Obstructive Pulmonary Disease: A Multicenter, Double-Blind, Randomized Controlled Trial
por: Wang, Genfa, et al.
Publicado: (2016) -
The Anti-Inflammatory Effects of Invigorating Kidney and Supplementing Qi Chinese Herbal Formulae in Asthma Patients
por: Kong, Lingwen, et al.
Publicado: (2017) -
Establishment and Evaluation of a Rat Model of Sidestream Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
por: Wang, Genfa, et al.
Publicado: (2018) -
Efficacy and safety of modified Bushen Yiqi formulas (MBYF) as an add-on to formoterol and budesonide in the management of COPD: study protocol for a multicentre, double-blind, placebo-controlled, parallel-group, randomized clinical trial: FB-MBYF Trial
por: Kong, Qing, et al.
Publicado: (2022) -
Efficacy and safety of Jia Wei Bushen Yiqi formulas as an adjunct therapy to systemic glucocorticoids on acute exacerbation of COPD: study protocol for a randomized, double-blinded, multi-center, placebo-controlled clinical trial
por: Kong, Qing, et al.
Publicado: (2020)